Close×

Twinings has launched its latest In’fuse cold water flavours to “liven up your water”, including its own drink bottle as part of the product range.

Teaming up with design agency Brand Opus, a droplet-shaped motif is featured in a variety of bold colours across each of the five flavour jars and trial packs, and acts as a handle to the water bottle.

Twinings In'fuse water bottle.
Twinings In'fuse custom water bottle.

Twinings innovation manager Eva Leibel said its focus in designing this range was to disrupt shoppers at shelf on both a brand and category level.

“As a traditional tea brand, we needed to cue ‘cold' in a hot beverage environment using key colours and semiotics to cue cold hydration,” she said.

“For example, both the silver lid and the transparent jar were purposefully chosen to cue cold water, [as well as] selecting a light shade of blue for the water bottle cap to help communicate the nature of the product to consumers.”

Working with brand merchandise supplier Inck, Leibel said the introduction of the water bottle was critical in communicating to shoppers the products were created for cold water and on-the-go hydration.

“The water bottle was highlighted as a key lifestyle accessory that our target audience (women 18-35 years) used in their daily life, helping them to stay hydrated and refreshed all day long, on the go, at work, at home in the car and out and about,” she said.

Twinings also teamed with Australian media personality and health coach Rachael Finch as the brand ambassador for the In’fuse range.

Food & Drink Business

The Top 10 remained a stable list this year, with five companies holding their position – Fonterra (#1), JBS (#2), Coca-Cola Europacific Partners (#3), Asahi (#4), and Thomas Foods International (#7). The biggest change was Treasury Wine Estates dropping out of the list, from #10 to #13.

Food & Drink Business and IBISWorld present this year’s Top 100 companies, a ranking of Australia’s largest food and drink companies by revenue. This year reflects a sector positioning itself for immediate term viability and long-term competitiveness.

The surge in usage of ‘GLP-1’-style weight loss medications is seeing a “ripple effect” begin to unfold, impacting eating patterns in a number of countries around the world, Rabobank says in recently released research.